Publicacións en colaboración con investigadores/as de Universidad de Jaén (19)

2020

  1. Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)

    Cancer Gene Therapy

  2. Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents

    AAPS PharmSciTech, Vol. 21, Núm. 5

  3. Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer

    Cancer Gene Therapy, Vol. 27, Núm. 9, pp. 657-668

2019

  1. Double origin of the extensor hallucis longus muscle: a case report

    Surgical and Radiologic Anatomy, Vol. 41, Núm. 12, pp. 1421-1423

  2. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview

    Cancer Biology and Medicine, Vol. 16, Núm. 4, pp. 688-699

2018

  1. DNA methylation patterns as molecular biomarkers: An overview in colorectal cancer

    European Journal of Anatomy, Vol. 22, Núm. 4, pp. 303-316

  2. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review

    Nutrition and Cancer, Vol. 70, Núm. 4, pp. 569-578

2017

  1. Gastrointestinal stromal tumours: An actualized overview

    European Journal of Anatomy, Vol. 21, Núm. 2, pp. 97-112

  2. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

    European Journal of Pharmaceutical Sciences, Vol. 102, pp. 24-34

2016

  1. Last advances in nanocarriers-based drug delivery systems for colorectal cancer

    Current Drug Delivery, Vol. 13, Núm. 6, pp. 830-838

2015

  1. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(Butylcyanoacrylate) nanoparticles

    International Journal of Nanomedicine, Vol. 10, pp. 1291-1306

  2. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles

    Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444

  3. Nanopartículas Magnéticas en el Diagnóstico y Tratamiento del Cáncer

    Actualidad médica, Tomo 100, Núm. 796, pp. 139-145

  4. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer

    AAPS Journal, Vol. 17, Núm. 4, pp. 918-929

  5. Temozolomide resistance in glioblastoma cell lines: Implication of MGMT, MMR, P-glycoprotein and CD133 expression

    PLoS ONE, Vol. 10, Núm. 10

2014

  1. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: Review of recent patents

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Núm. 1, pp. 21-34

  2. CO-99 Nanopartículas de Poli(ε-caprolactona) portadoras de 5-Fluorouracilo para mejorar el tratamiento del cáncer de colon avanzado

    I Congreso Nacional Multidisciplinar de Jóvenes Investigadores: libro de Actas : Facultad de Ciencias, Universidad de Granada 19, 20 y 21 de febrero de 2014 (Asociación de Investigadores Extranjeros (AINVEX)), pp. 227-232

2013

  1. Colon cancer therapy: Recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 13, Núm. 8, pp. 1204-1216

  2. Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART A, pp. 329-338